Researchers track Real-World success of triple therapy for myeloma
NCT ID NCT06933277
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 23 times
Summary
This study watches how well a combination of three drugs (selinexor, bortezomib, and dexamethasone) works for adults with multiple myeloma who have already tried 1 to 3 other treatments. It does not test a new drug but collects information from regular medical care to see how long the cancer stays under control. About 159 people will take part, and the study will last about 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aou Careggi - Sod Ematologia
RECRUITINGFlorence, Italy
Contact
Conditions
Explore the condition pages connected to this study.